Skip to main content
SpringerLink
Log in

DNA Methylation in Colorectal Cancer: Multiple Facets of Tumorigenesis

  • Chapter
Genetics of Colorectal Cancer

Part of the book series: Cancer Genetics ((CANGENETICS))

  • 1163 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aaltonen, L. A., P. Peltomaki, et al. (1993). “Clues to the pathogenesis of familial colorectal cancer.” Science 260(5109): 812–6.

    Article  PubMed  CAS  Google Scholar 

  • Ahuja, N. and J. P. Issa (2000). “Aging, methylation and cancer.” Histol Histopathol 15(3): 835–42.

    PubMed  CAS  Google Scholar 

  • Ahuja, N., Q. Li, et al. (1998). “Aging and DNA methylation in colorectal mucosa and cancer.” Cancer Res 58(23): 5489–94.

    PubMed  CAS  Google Scholar 

  • Akiyama, Y., N. Watkins, et al. (2003). “GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.” Mol Cell Biol 23(23): 8429–39.

    Article  PubMed  CAS  Google Scholar 

  • An, C., I. S. Choi, et al. (2005). “Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.” Clin Cancer Res 11(2 Pt 1): 656–63.

    PubMed  CAS  Google Scholar 

  • Anacleto, C., A. M. Leopoldino, et al. (2005). “Colorectal cancer “methylator phenotype”: fact or artifact?” Neoplasia 7(4): 331–5.

    Article  PubMed  CAS  Google Scholar 

  • Bariol, C., C. Suter, et al. (2003). “The relationship between hypomethylation and CpG island methylation in colorectal neoplasia.” Am J Pathol 162(4): 1361–71.

    Article  PubMed  CAS  Google Scholar 

  • Baumann, S., G. Keller, et al. (2006). “The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promoter hypermethylation in esophageal adenocarcinoma.” Int J Cancer 119(2): 264–8.

    Article  PubMed  CAS  Google Scholar 

  • Baylin, S. B. and J. E. Ohm (2006). “Epigenetic gene silencing in cancer–a mechanism for early oncogenic pathway addiction?” Nat Rev Cancer 6(2): 107–16.

    Article  PubMed  CAS  Google Scholar 

  • Baylin, S. B., J. W. Hoppener, et al. (1986). “DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.” Cancer Res 46(6): 2917–22.

    PubMed  CAS  Google Scholar 

  • Beach, R., A. O. Chan, et al. (2005). “BRAF mutations in aberrant crypt foci and hyperplastic polyposis.” Am J Pathol 166(4): 1069–75.

    Article  PubMed  CAS  Google Scholar 

  • Beke, L., M. Nuytten, et al. (2007). “The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.” Oncogene 26: 4590–5.

    Article  PubMed  CAS  Google Scholar 

  • Bell, A. C. and G. Felsenfeld (2000). “Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.” Nature 405(6785): 482–5.

    Article  PubMed  CAS  Google Scholar 

  • Bell, A. C., A. G. West, et al. (2001). “Insulators and boundaries: versatile regulatory elements in the eukaryotic.” Science 291(5503): 447–50.

    Article  PubMed  CAS  Google Scholar 

  • Belshaw, N. J., G. O. Elliott, et al. (2004). “Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.” Cancer Epidemiol Biomarkers Prev 13(9): 1495–501.

    PubMed  CAS  Google Scholar 

  • Bird, A. P. (1986). “CpG-rich islands and the function of DNA methylation.” Nature 321 (6067): 209–13.

    Article  PubMed  CAS  Google Scholar 

  • Boyer, L. A., K. Plath, et al. (2006). “Polycomb complexes repress developmental regulators in murine embryonic stem cells.” Nature 441(7091): 349–53.

    Article  PubMed  CAS  Google Scholar 

  • Bryant, R. J., N. A. Cross, et al. (2007). “EZH2 promotes proliferation and invasiveness of prostate cancer cells.” Prostate 67(5): 547–56.

    Article  PubMed  CAS  Google Scholar 

  • Butler, M. G. (2002). “Imprinting disorders: non-Mendelian mechanisms affecting growth.” J Pediatr Endocrinol Metab 15 Suppl 5: 1279–88.

    PubMed  CAS  Google Scholar 

  • Chan, A. O., R. R. Broaddus, et al. (2002a). “CpG island methylation in aberrant crypt foci of the colorectum.” Am J Pathol 160(5): 1823–30.

    Article  CAS  Google Scholar 

  • Chan, A. O., J. P. Issa, et al. (2002b). “Concordant CpG island methylation in hyperplastic polyposis.” Am J Pathol 160(2): 529–36.

    Article  CAS  Google Scholar 

  • Chan, T. L., S. T. Yuen, et al. (2006). “Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.” Nat Genet 38(10): 1178–83.

    Article  PubMed  CAS  Google Scholar 

  • Chang, M. S., H. Uozaki, et al. (2006). “CpG island methylation status in gastric carcinoma with and without infection of Epstein–Barr virus.” Clin Cancer Res 12(10): 2995–3002.

    Article  PubMed  CAS  Google Scholar 

  • Chong, S., N. A. Youngson, et al. (2007). “Heritable germline epimutation is not the same as transgenerational epigenetic inheritance.” Nat Genet 39(5): 574–5; author reply 575–6.

    Article  PubMed  CAS  Google Scholar 

  • Clement, G., R. Braunschweig, et al. (2006). “Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation.” J Pathol 208(1): 100–7.

    Article  PubMed  CAS  Google Scholar 

  • Costa, V. L., R. Henrique, et al. (2007). “Epigenetic markers for molecular detection of prostate cancer.” Dis Markers 23(1–2): 31–41.

    PubMed  CAS  Google Scholar 

  • Cui, H., P. Onyango, et al. (2002). “Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.” Cancer Res 62(22): 6442–6.

    PubMed  CAS  Google Scholar 

  • Cui, H., M. Cruz-Correa, et al. (2003). “Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.” Science 299(5613): 1753–5.

    Article  PubMed  CAS  Google Scholar 

  • Das, R., N. Dimitrova, et al. (2006). “Computational prediction of methylation status in human genomic sequences.” Proc Natl Acad Sci USA 103(28): 10713–6.

    Article  PubMed  CAS  Google Scholar 

  • Delaval, K., A. Wagschal, et al. (2006). “Epigenetic deregulation of imprinting in congenital diseases of aberrant growth.” Bioessays 28(5): 453–9.

    Article  PubMed  CAS  Google Scholar 

  • Diala, E. S. and R. M. Hoffman (1982). “Hypomethylation of HeLa cell DNA and the absence of 5-methylcytosine in SV40 and adenovirus (type 2) DNA: analysis by HPLC.” Biochem Biophys Res Commun 107: 19–26.

    Article  PubMed  CAS  Google Scholar 

  • Diala, E. S., M. S. Cheah, et al. (1983). “Extent of DNA methylation in human tumor cells.” J Natl Cancer Inst 71: 755–64.

    PubMed  CAS  Google Scholar 

  • Douglas, J. A., S. B. Gruber, et al. (2005). “History and molecular genetics of Lynch syndrome in family G: a century later.” JAMA 294(17): 2195–202.

    Article  PubMed  CAS  Google Scholar 

  • Ducasse, M. and M. A. Brown (2006). “Epigenetic aberrations and cancer.” Mol Cancer 5: 60.

    Article  PubMed  CAS  Google Scholar 

  • Eads, C. A., K. D. Danenberg, et al. (1999). “CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.” Cancer Res 59(10): 2302–6.

    PubMed  CAS  Google Scholar 

  • Eden, A., F. Gaudet, et al. (2003). “Chromosomal instability and tumors promoted by DNA hypomethylation.” Science 300(5618): 455.

    Article  PubMed  CAS  Google Scholar 

  • Englander, E. W., A. P. Wolffe, et al. (1993). “Nucleosome interactions with a human Alu element. Transcriptional repression and effects of template methylation.” J Biol Chem 268(26): 19565–73.

    PubMed  CAS  Google Scholar 

  • Esteller, M., M. F. Fraga, et al. (2001). “DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.” Hum Mol Genet 10(26): 3001–7.

    Article  PubMed  CAS  Google Scholar 

  • Feinberg, A. P. (2007). “Phenotypic plasticity and the epigenetics of human disease.” Nature 447(7143): 433–40.

    Article  PubMed  CAS  Google Scholar 

  • Feinberg, A. P. and B. Vogelstein (1983a). “Hypomethylation distinguishes genes of some human cancers from their normal counterparts.” Nature 301(5895): 89–92.

    Article  CAS  Google Scholar 

  • Feinberg, A. P. and B. Vogelstein (1983b). “Hypomethylation of ras oncogenes in primary human cancers.” Biochem Biophys Res Commun 111(1): 47–54.

    Article  CAS  Google Scholar 

  • Feng, Q., S. E. Hawes, et al. (2007). “Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia.” Cancer Epidemiol Biomarkers Prev 16(6): 1178–84.

    Article  PubMed  CAS  Google Scholar 

  • Fiskus, W., M. Pranpat, et al. (2006). “Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.” Mol Cancer Ther 5(12): 3096–104.

    Article  PubMed  CAS  Google Scholar 

  • Flatau, E., E. Bogenmann, et al. (1983). “Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants.” Cancer Res 43: 4901–5.

    PubMed  CAS  Google Scholar 

  • Frazier, M. L., L. Xi, et al. (2003). “Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.” Cancer Res 63(16): 4805–8.

    PubMed  CAS  Google Scholar 

  • Frigola, J., J. Song, et al. (2006). “Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.” Nat Genet 38(5): 540–9.

    Article  PubMed  CAS  Google Scholar 

  • Gama-Sosa, M. A., V. A. Slagel, et al. (1983). “The 5-methylcytosine content of DNA from human tumors.” Nucleic Acids Res 11: 6883–94.

    Article  Google Scholar 

  • Gaudet, F., J. G. Hodgson, et al. (2003). “Induction of tumors in mice by genomic hypomethylation.” Science 300(5618): 489–92.

    Article  PubMed  CAS  Google Scholar 

  • Gazzoli, I., M. Loda, et al. (2002). “A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmeth-ylated allele in the resulting microsatellite instability-high tumor.” Cancer Res 62(14): 3925–8.

    PubMed  CAS  Google Scholar 

  • Goelz, S. E., B. Vogelstein, et al. (1985). “Hypomethylation of DNA from benign and malignant human colon neoplasms.” Science 228(4696): 187–90.

    Article  PubMed  CAS  Google Scholar 

  • Goldstein, N. S. (2005). “Clinical significance of (sessile) serrated adenomas: another piece of the puzzle.” Am J Clin Pathol 123(3): 329–30.

    Article  PubMed  Google Scholar 

  • Goldstein, N. S., P. Bhanot, et al. (2003). “Hyperplastic-like colon polyps that preceded microsat-ellite-unstable adenocarcinomas.” Am J Clin Pathol 119(6): 778–96.

    Article  PubMed  Google Scholar 

  • Hamilton, J. P., F. Sato, et al. (2006). “Reprimo methylation is a potential biomarker of Barrett's-associated esophageal neoplastic progression.” Clin Cancer Res 12(22): 6637–42.

    Article  PubMed  CAS  Google Scholar 

  • Hawkins, N. J. and R. L. Ward (2001). “Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.” J Natl Cancer Inst 93(17): 1307–13.

    Article  PubMed  CAS  Google Scholar 

  • Hawkins, N. J., C. Bariol, et al. (2002). “The serrated neoplasia pathway.” Pathology 34(6): 548–55.

    PubMed  CAS  Google Scholar 

  • Hayslip, J. and A. Montero (2006). “Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.” Mol Cancer 5: 44.

    Article  PubMed  CAS  Google Scholar 

  • Herman, J. G., A. Merlo, et al. (1995). “Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.” Cancer Res 55(20): 4525–30.

    PubMed  CAS  Google Scholar 

  • Herman, J. G., A. Umar, et al. (1998). “Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.” Proc Natl Acad Sci USA 95(12): 6870–5.

    Article  PubMed  CAS  Google Scholar 

  • Hitchins, M., R. Williams, et al. (2005). “MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.” Gastroenterology 129(5): 1392–9.

    Article  PubMed  CAS  Google Scholar 

  • Hitchins, M. P., J. J. Wong, et al. (2007). “Inheritance of a cancer-associated MLH1 germ-line epimutation.” N Engl J Med 356(7): 697–705.

    Article  PubMed  CAS  Google Scholar 

  • Hochedlinger, K., R. Blelloch, et al. (2004). “Reprogramming of a melanoma genome by nuclear transplantation.” Genes Dev 18(15): 1875–85.

    Article  PubMed  CAS  Google Scholar 

  • Holliday, R. (1987). “The inheritance of epigenetic defects.” Science 238(4824): 163–70.

    Article  PubMed  CAS  Google Scholar 

  • Holm, T. M., L. Jackson-Grusby, et al. (2005). “Global loss of imprinting leads to widespread tumorigenesis in adult mice.” Cancer Cell 8(4): 275–85.

    Article  PubMed  CAS  Google Scholar 

  • Horsthemke, B. (2006). “Epimutations in human disease.” Curr Top Microbiol Immunol 310: 45–59.

    Article  PubMed  CAS  Google Scholar 

  • Iacopetta, B., W. Q. Li, et al. (2006). “BRAF mutation and gene methylation frequencies of colorectal tumors with microsatellite instability increase markedly with patient age.” Gut 55(8): 1213–4.

    Article  PubMed  CAS  Google Scholar 

  • Ionov, Y., M. A. Peinado, et al. (1993). “Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.” Nature 363(6429): 558–61.

    Article  PubMed  CAS  Google Scholar 

  • Issa, J. P. (1999). “Aging, DNA methylation and cancer.” Crit Rev Oncol Hematol 32(1): 31–43.

    Article  PubMed  CAS  Google Scholar 

  • Issa, J. P. (2000). “CpG-island methylation in aging and cancer.” Curr Top Microbiol Immunol 249: 101–18.

    Article  PubMed  CAS  Google Scholar 

  • Issa, J. P. (2004). “CpG island methylator phenotype in cancer.” Nat Rev Cancer 4(12): 988–93.

    Article  PubMed  CAS  Google Scholar 

  • Issa, J. P., N. Ahuja, et al. (2001). “Accelerated age-related CpG island methylation in ulcerative colitis.” Cancer Res 61(9): 3573–7.

    PubMed  CAS  Google Scholar 

  • Issa, J. P., L. Shen, et al. (2005). “CIMP, at last.” Gastroenterology 129(3): 1121–4.

    Article  PubMed  CAS  Google Scholar 

  • Jackson-Grusby, L., C. Beard, et al. (2001). “Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.” Nat Genet 27(1): 31–9.

    Article  CAS  Google Scholar 

  • Jaenisch, R. and A. Bird (2003). “Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.” Nat Genet 33 Suppl: 245–54.

    Article  PubMed  CAS  Google Scholar 

  • Jass, J. R. (2001). “Serrated route to colorectal cancer: back street or super highway?” J Pathol 193(3): 283–5.

    Article  PubMed  CAS  Google Scholar 

  • Jass, J. R. (2003). “Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer.” Am J Clin Pathol 119(6): 773–5.

    Article  PubMed  Google Scholar 

  • Jass, J. R. (2004). “Hyperplastic polyps and colorectal cancer: is there a link?” Clin Gastroenterol Hepatol 2(1): 1–8.

    Article  PubMed  Google Scholar 

  • Jass, J. R., K. A. Do, et al. (1998). “Morphology of sporadic colorectal cancer with DNA replication errors.” Gut 42(5): 673–9.

    Article  PubMed  CAS  Google Scholar 

  • Jass, J. R., H. Iino, et al. (2000). “Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.” Gut 47(1): 43–9.

    Article  PubMed  CAS  Google Scholar 

  • Jelinic, P. and P. Shaw (2007). “Loss of imprinting and cancer.” J Pathol 211(3): 261–8.

    Article  PubMed  CAS  Google Scholar 

  • Jones, P. A. and P. W. Laird (1999). “Cancer epigenetics comes of age.” Nat Genet 21(2): 163–7.

    Article  PubMed  CAS  Google Scholar 

  • Kambara, T., L. A. Simms, et al. (2004). “BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.” Gut 53(8): 1137–44.

    Article  PubMed  CAS  Google Scholar 

  • Kang, S., H. S. Kim, et al. (2007). “Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.” Gynecol Oncol 105(3): 662–6.

    Article  PubMed  CAS  Google Scholar 

  • Karpf, A. R. and S. Matsui (2005). “Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.” Cancer Res 65(19): 8635–9.

    Article  PubMed  CAS  Google Scholar 

  • Kawakami, K., A. Ruszkiewicz, et al. (2006). “DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.” Br J Cancer 94(4): 593–8.

    Article  PubMed  CAS  Google Scholar 

  • Keshet, I., Y. Schlesinger, et al. (2006). “Evidence for an instructive mechanism of de novo methylation in cancer cells.” Nat Genet 38(2): 149–53.

    Article  PubMed  CAS  Google Scholar 

  • Kleer, C. G., Q. Cao, et al. (2003). “EZH2 is a marker of aggressive breast cancer and promotes neo-plastic transformation of breast epithelial cells.” Proc Natl Acad Sci USA 100(20): 11606–11.

    Article  PubMed  CAS  Google Scholar 

  • Lagerstedt Robinson, K., T. Liu, et al. (2007). “Lynch syndrome (hereditary nonpolyposis color-ectal cancer) diagnostics.” J Natl Cancer Inst 99(4): 291–9.

    Article  PubMed  CAS  Google Scholar 

  • Laird, P. W. (2003). “The power and the promise of DNA methylation markers.” Nat Rev Cancer 3(4): 253–66.

    Article  PubMed  CAS  Google Scholar 

  • Laird, P. W. (2005). “Cancer epigenetics.” Hum Mol Genet 14 Spec No 1: R65–76.

    Article  PubMed  CAS  Google Scholar 

  • Lee, T. I., R. G. Jenner, et al. (2006). “Control of developmental regulators by Polycomb in human embryonic stem cells.” Cell 125(2): 301–13.

    Article  PubMed  CAS  Google Scholar 

  • Lengauer, C., K. W. Kinzler, et al. (1997a). “DNA methylation and genetic instability in colorectal cancer cells.” Proc Natl Acad Sci USA 94(6): 2545–50.

    Article  CAS  Google Scholar 

  • Lengauer, C., K. W. Kinzler, et al. (1997b). “Genetic instability in colorectal cancers.” Nature 386(6625): 623–7.

    Article  CAS  Google Scholar 

  • Leung, S. Y., T. L. Chan, et al. (2007). “Reply to “Heritable germline epimutation is not the same as transgenerational epigenetic inheritance”.” Nat Genet 39(5): 576.

    Article  CAS  Google Scholar 

  • Li, S. C. and L. Burgart (2007). “Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps.” Arch Pathol Lab Med 131(3): 440–5.

    PubMed  Google Scholar 

  • Lippman, Z. and R. Martienssen (2004). “The role of RNA interference in heterochromatic silencing.” Nature 431(7006): 364–70.

    Article  PubMed  CAS  Google Scholar 

  • Lu, C., T. Bonome, et al. (2007). “Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.” Cancer Res 67(4): 1757–68.

    Article  PubMed  CAS  Google Scholar 

  • Maenaka, S., T. Hikichi, et al. (2006). “Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.” Oncol Rep 15(4): 791–5.

    PubMed  CAS  Google Scholar 

  • Mancini-DiNardo, D., S. J. Steele, et al. (2003). “A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer.” Hum Mol Genet 12(3): 283–94.

    Article  PubMed  CAS  Google Scholar 

  • Mancini-DiNardo, D., S. J. Steele, et al. (2006). “Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes.” Genes Dev 20(10): 1268–82.

    Article  CAS  Google Scholar 

  • Marker, P. C. (2007). “Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky G V, Translational and Functional Genomics Laboratory, Ordway Cancer Center, Ordway Research Institute, Inc., Center for Medical Sciences, Albany, NY.” Urol Oncol 25(3): 278–9.

    Article  CAS  Google Scholar 

  • Marsit, C. J., E. A. Houseman, et al. (2006). “Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.” Cancer Res 66(21): 10621–9.

    Article  PubMed  CAS  Google Scholar 

  • Matsuzaki, K., G. Deng, et al. (2005). “The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.” Clin Cancer Res 11(24 Pt 1): 8564–9.

    Article  PubMed  CAS  Google Scholar 

  • Mattioli, E., P. Vogiatzi, et al. (2007). “Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.” J Cell Physiol 210(1): 183–91.

    Article  PubMed  CAS  Google Scholar 

  • McGivern, A., C. V. Wynter, et al. (2004). “Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.” Fam Cancer 3(2): 101–7.

    Article  PubMed  CAS  Google Scholar 

  • Merlo, A., J. G. Herman, et al. (1995). “5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.” Nat Med 1(7): 686–92.

    Article  PubMed  CAS  Google Scholar 

  • Minoo, P., J. R. Jass (2006). “Senescence and Serration: a new twist to an old tale.” J Pathol 210(2): 137–40.

    Article  PubMed  CAS  Google Scholar 

  • Minoo, P., K. Baker, et al. (2006). “Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.” Gut 55(10): 1467–74.

    Article  PubMed  CAS  Google Scholar 

  • Minoo, P., M. Moyer, et al. (2007). “Role of BRAF-V600E in the serrated pathway of colorectal tumorigenesis.” J Pathol 212(2): 124–33.

    Article  PubMed  CAS  Google Scholar 

  • Mintz, B. and K. Illmensee (1975). “Normal genetically mosaic mice produced from malignant teratocarcinoma cells.” Proc Natl Acad Sci USA 72(9): 3585–9.

    Article  PubMed  CAS  Google Scholar 

  • Miyakura, Y., K. Sugano, et al. (2004). “Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.” Clin Gastroenterol Hepatol 2(2): 147–56.

    Article  PubMed  CAS  Google Scholar 

  • Nakagawa, H., R. B. Chadwick, et al. (2001a). “Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.” Proc Natl Acad Sci USA 98(2): 591–6.

    Article  CAS  Google Scholar 

  • Nakagawa, H., G. J. Nuovo, et al. (2001b). “Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.” Cancer Res 61: 6991–5.

    CAS  Google Scholar 

  • Ogino, S., M. Cantor, et al. (2006a). “CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.” Gut 55(7): 1000–6.

    Article  CAS  Google Scholar 

  • Ogino, S., R. D. Odze, et al. (2006b). “Correlation of pathologic features with CpG island meth-ylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.” Am J Surg Pathol 30(9): 1175–83.

    Article  Google Scholar 

  • Ogino, S., T. Kawasaki, et al. (2007a). “Evaluation of markers for CpG Island Methylator Phenotype (CIMP) in colorectal cancer by a large population-based sample.” J Mol Diagn 9(3): 305–14.

    Article  CAS  Google Scholar 

  • Ogino, S., T. Kawasaki, et al. (2007b). “18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.” BMC Cancer 7: 72.

    Article  CAS  Google Scholar 

  • Ohlsson, R. (2004). “Loss of IGF2 imprinting: mechanisms and consequences.” Novartis Found Symp 262: 108–21; discussion 121–4, 265–8.

    Article  PubMed  CAS  Google Scholar 

  • Ohm, J. E., K. M. McGarvey, et al. (2007). “A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.” Nat Genet 39(2): 237–42.

    Article  PubMed  CAS  Google Scholar 

  • Ostertag, E. M. and H. H. Kazazian (2005). “Genetics: LINEs in mind.” Nature 435(7044): 890–1.

    Article  PubMed  CAS  Google Scholar 

  • Pao, M. M., G. Liang, et al. (2000). “DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines.” Oncogene 19: 943–52.

    Article  PubMed  CAS  Google Scholar 

  • Perri, F., R. Cotugno, et al. (2007). “Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication.” Am J Gastroenterol 102(11): 1361–71.

    Article  PubMed  CAS  Google Scholar 

  • Rashid, A. and J. P. Issa (2004). “CpG island methylation in gastroenterologic neoplasia: a maturing field.” Gastroenterology 127(5): 1578–88.

    Article  PubMed  CAS  Google Scholar 

  • Robertson, K. D. (2001). “DNA methylation, methyltransferases, and cancer.” Oncogene 20(24): 3139–55.

    Article  PubMed  CAS  Google Scholar 

  • Robertson, K. D., E. Uzvolgyi, et al. (1999). “The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.” Nucleic Acids Res 27(11): 2291–8.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez, J., J. Frigola, et al. (2006). “Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.” Cancer Res 66(17): 8462–9468.

    Article  PubMed  CAS  Google Scholar 

  • Sakatani, T., A. Kaneda, et al. (2005). “Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.” Science 307(5717): 1976–8.

    Article  PubMed  CAS  Google Scholar 

  • Samowitz, W. S., H. Albertsen, et al. (2005a). “Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.” Gastroenterology 129(3): 837–45.

    Article  CAS  Google Scholar 

  • Samowitz, W. S., C. Sweeney, et al. (2005b). “Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.” Cancer Res 65(14): 6063–9.

    Article  CAS  Google Scholar 

  • Samowitz, W. S., H. Albertsen, et al. (2006). “Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.” J Natl Cancer Inst 98(23): 1731–8.

    Article  PubMed  CAS  Google Scholar 

  • Santos-Reboucas, C. B. and M. M. Pimentel (2007). “Implication of abnormal epigenetic patterns for human diseases.” Eur J Hum Genet 15(1): 10–7.

    Article  PubMed  CAS  Google Scholar 

  • Sathyanarayana, U. G., A. Y. Moore, et al. (2007). “Sun exposure related methylation in malignant and non-malignant skin lesions.” Cancer Lett 245(1–2): 112–20.

    Article  PubMed  CAS  Google Scholar 

  • Schlesinger, Y., R. Straussman, et al. (2007). “Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.” Nat Genet 39(2): 232–6.

    Article  PubMed  CAS  Google Scholar 

  • Serman, A., M. Vlahovic, et al. (2006). “DNA methylation as a regulatory mechanism for gene expression in mammals.” Coll Antropol 30(3): 665–71.

    PubMed  CAS  Google Scholar 

  • Shames, D. S., J. D. Minna, et al. (2007). “DNA methylation in health, disease, and cancer.” Curr Mol Med 7(1): 85–102.

    Article  PubMed  CAS  Google Scholar 

  • Sharrard, R. M., J. A. Royds, et al. (1992). “Patterns of methylation of the c-myc gene in human colorectal cancer progression.” Br J Cancer 65(5): 667–72.

    Article  PubMed  CAS  Google Scholar 

  • Shen, L., N. Ahuja, et al. (2002). “DNA methylation and environmental exposures in human hepatocellular carcinoma.” J Natl Cancer Inst 94: 755–61.

    Article  PubMed  CAS  Google Scholar 

  • Shen, L., Y. Kondo, et al. (2005). “MGMT promoter methylation and field defect in sporadic colorectal cancer.” J Natl Cancer Inst 97(18): 1330–8.

    Article  PubMed  CAS  Google Scholar 

  • Shi, B., J. Liang, et al. (2007). “Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.” Mol Cell Biol 27(14): 5105–19.

    Article  PubMed  CAS  Google Scholar 

  • Simms, L. A., T. T. Zou, et al. (1997). “Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers.” Oncogene 14(21): 2613–8.

    Article  PubMed  CAS  Google Scholar 

  • Slattery, M. L., K. Curtin, et al. (2007). “Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.” Int J Cancer 120(3): 656–63.

    Article  PubMed  CAS  Google Scholar 

  • Slattery, M. L., W. Samowitz, et al. (2004). “CYP1A1, cigarette smoking, and colon and rectal cancer.” Am J Epidemiol 160: 842–52.

    Article  Google Scholar 

  • Song, G. A., G. Deng, et al. (2005). “Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics.” Int J Oncol 26(3): 745–50.

    PubMed  CAS  Google Scholar 

  • Squazzo, S. L., H. O'Geen, et al. (2006). “Suz12 binds to silenced regions of the genome in a cell-type-specific manner.” Genome Res 16(7): 890–900.

    Article  PubMed  CAS  Google Scholar 

  • Suter, C. M. and D. I. Martin (2007a). “Inherited epimutation or a haplotypic basis for the propensity to silence?” Nat Genet 39(5): 573; author reply 576.

    Article  CAS  Google Scholar 

  • Suter, C. M. and D. I. Martin (2007b). “Reply to “Heritable germline epimutation is not the same as transgenerational epigenetic inheritance”.” Nat Genet 39(5): 575–6.

    Article  CAS  Google Scholar 

  • Suter, C. M., D. I. Martin, et al. (2004). “Germline epimutation of MLH1 in individuals with multiple cancers.” Nat Genet 36(5): 497–501.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki, M., H. Shigematsu, et al. (2005). “DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers.” Br J Cancer 93(9): 1029–37.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki, M., H. Shigematsu, et al. (2006). “Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.” Cancer 106(10): 2200–7.

    Article  PubMed  CAS  Google Scholar 

  • Tanaka, H., G. Deng, et al. (2006). “BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.” Int J Cancer 118(11): 2765–71.

    Article  PubMed  CAS  Google Scholar 

  • Tanay, A., A. H. O'Donnell, et al. (2007). “Hyperconserved CpG domains underlie Polycomb-binding sites.” Proc Natl Acad Sci USA 104(13): 5521–6.

    Article  PubMed  CAS  Google Scholar 

  • Thibodeau, S. N., G. Bren, et al. (1993). “Microsatellite instability in cancer of the proximal colon.” Science 260(5109): 816–9.

    Article  PubMed  CAS  Google Scholar 

  • Torlakovic, E. and D. C. Snover (1996). “Serrated adenomatous polyposis in humans.” Gastroenterology 110(3): 748–55.

    Article  PubMed  CAS  Google Scholar 

  • Toyota, M. and J. P. Issa (1999). “CpG island methylator phenotypes in aging and cancer.” Semin Cancer Biol 9(5): 349–57.

    Article  PubMed  CAS  Google Scholar 

  • Toyota, M. and J. P. Issa (2002). “Methylated CpG island amplification for methylation analysis and cloning differentially methylated sequences.” Methods Mol Biol 200: 101–10.

    PubMed  CAS  Google Scholar 

  • Toyota, M., M. Ohe-Toyota, et al. (2000). “Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.” Proc Natl Acad Sci USA 97(2): 710–5.

    Article  PubMed  CAS  Google Scholar 

  • Valle, L., P. Carbonell, et al. (2007). “MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.” Clin Genet 71(3): 232–7.

    Article  PubMed  CAS  Google Scholar 

  • van Rijnsoever, M., F. Grieu, et al. (2002). “Characterisation of colorectal cancers showing hyper-methylation at multiple CpG islands.” Gut 51(6): 797–802.

    Article  PubMed  Google Scholar 

  • Vandrovcova, J., K. Lagerstedt-Robinsson, et al. (2006). “Somatic BRAF-V600E mutations in familial colorectal cancer.” Cancer Epidemiol Biomarkers Prev 15(11): 2270–3.

    Article  PubMed  CAS  Google Scholar 

  • Varambally, S., S. M. Dhanasekaran, et al. (2002). “The polycomb group protein EZH2 is involved in progression of prostate cancer.” Nature 419(6907): 624–9.

    Article  PubMed  CAS  Google Scholar 

  • Vilkaitis, G., I. Suetake, et al. (2005). “Processive methylation of hemimethylated CpG sites by mouse Dnmt1 DNA methyltransferase.” J Biol Chem 280(1): 64–72.

    PubMed  CAS  Google Scholar 

  • Vogelstein, B., E. R. Fearon, et al. (1988). “Genetic alterations during colorectal-tumor development.” N Engl J Med 319(9): 525–32.

    Article  PubMed  CAS  Google Scholar 

  • Walsh, C. P., J. R. Chaillet, et al. (1998). “Transcription of IAP endogenous retroviruses is constrained by cytosine methylation.” Nat Genet 20(2): 116–7.

    Article  PubMed  CAS  Google Scholar 

  • Weisenberger, D. J., K. D. Siegmund, et al. (2006). “CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.” Nat Genet 38(7): 787–93.

    Article  PubMed  CAS  Google Scholar 

  • Widschwendter, M., H. Fiegl, et al. (2007). “Epigenetic stem cell signature in cancer.” Nat Genet 39(2): 157–8.

    Article  PubMed  CAS  Google Scholar 

  • Wong, D. J., S. A. Foster, et al. (1999). “Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest.” Mol Cell Biol 19(8): 5642–51.

    PubMed  CAS  Google Scholar 

  • Wong, J. J., N. J. Hawkins, et al. (2007a). “Colorectal cancer: a model for epigenetic tumorigen-esis.” Gut 56(1): 140–8.

    Article  CAS  Google Scholar 

  • Wong, C. K., Z. Chen, et al. (2007b). “Polycomb group protein RING1B is a direct substrate of Caspases-3 and -9.” Biochim Biophys Acta 1773(6): 844–52.

    Article  CAS  Google Scholar 

  • Wu, D. L., F. Y. Sui, et al. (2006). “Methylation in esophageal carcinogenesis.” World J Gastroenterol 12(43): 6933–40.

    PubMed  CAS  Google Scholar 

  • Wynter, C. V., M. D. Walsh, et al. (2004). “Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer.” Gut 53(4): 573–80.

    Article  PubMed  CAS  Google Scholar 

  • Yamashita, K., T. Dai, et al. (2003). “Genetics supersedes epigenetics in colon cancer phenotype.” Cancer Cell 4(2): 121–31.

    Article  PubMed  CAS  Google Scholar 

  • Yang, S., F. A. Farraye, et al. (2004). “BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.” Am J Surg Pathol 28(11): 1452–9.

    Article  PubMed  Google Scholar 

  • Yasui, W., K. Sentani, et al. (2006). “Molecular pathobiology of gastric cancer.” Scand J Surg 95(4): 225–31.

    PubMed  CAS  Google Scholar 

  • Yoder, J. A., C. P. Walsh, et al. (1997). “Cytosine methylation and the ecology of intragenomic parasites.” Trends Genet 13(8): 335–40.

    Article  PubMed  CAS  Google Scholar 

  • Young, J., K. G. Biden, et al. (2001a). “HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.” Proc Natl Acad Sci USA 98(1): 265–70.

    Article  CAS  Google Scholar 

  • Young, J., L. A. Simms, et al. (2001b). “Features of colorectal cancers with high-level microsatel-lite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.” Am J Pathol 159(6): 2107–16.

    Article  CAS  Google Scholar 

  • Young, J., M. A. Barker, et al. (2005). “Evidence for BRAF mutation and variable levels of mic-rosatellite instability in a syndrome of familial colorectal cancer.” Clin Gastroenterol Hepatol 3(3): 254–63.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, Y., R. Cao, et al. (2004). “Mechanism of Polycomb group gene silencing.” Cold Spring Harb Symp Quant Biol 69: 309–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Queensland Institute of Medical Research, Queensland

    Joanne P. Young & Peter W. Laird

Authors
  1. Joanne P. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter W. Laird
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanne P. Young .

Editor information

Editors and Affiliations

  1. Member and Senior Advisor Fred Hutchinson Cancer Research Center, M4-B814, PO Box 19024, Seattle, WA, 98109-1024, USA

    John D. Potter MD, PhD

  2. Department of Medical Genetics, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA

    Noralane M. Lindor MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Young, J.P., Laird, P.W. (2009). DNA Methylation in Colorectal Cancer: Multiple Facets of Tumorigenesis. In: Potter, J.D., Lindor, N.M. (eds) Genetics of Colorectal Cancer. Cancer Genetics. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09568-4_4

Download citation

Publish with us

Policies and ethics

Search

Navigation